[armada651]

There is certainly an argument to be made that the US pays the R&D costs for the rest of the world. Most new drugs end up in public healthcare systems as if the pharmaceutical company is throwing an old product into the discount bin.

However some of these new drugs are so expensive that some countries are now refusing to allow certain new cancer drugs on the market. Simply because the exorbitant price compared to the questionable gains in quality of life doesn't make sense anymore.